NANCY OLSON: Open Payments
NPI 1376674721 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 35 payments from 7 companies in 2025. Trend: 2023 $1,627 · 2024 $942 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $420 |
| Lundbeck LLC | 9 | $152 |
| Alkermes, Inc. | 1 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
Products named: Auvelity, REXULTI, LYBALVI, FANAPT, VRAYLAR, TRINTELLIX.
Industry payments across CT — which companies pay providers there.
